• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Wockhardt Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Wockhardt
  • BSE Code : 8021.0
  • ISIN : INE049B01025
1,424.40 15 (1.08%)
  • As on 31 Mar 2025 (EOD)
  • Today’s Low

    1,406.00
  • Today’s High

    1,469.90
  • Open

    1,430.00
  • Perv Close

    1,409.20
  • 52W Low

    490.15
  • 52W High

    1,679.90

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    23,144.44

  • Div & Yield %

    0.00

  • Book Value(₹)

    170.15

  • Debt-Equity Ratio

    1.08

  • AGM Date

    28-Mar-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.68

  • Mar.Cap (₹Cr.)

    23,144.44

  • RONW (%)

    -12.34

  • ROCE (%)

    -0.86

Score Board

  • Equity (₹ in Cr.)

    81.24

  • BV (₹)

    170.20

  • Sales( ₹ in Cr.)

    1,154.00

  • NP (in Cr.)

    -408.00

  • NP Var(%)

    -77.0

  • Div%

    0.0

  • CPS (₹)

    -14.30

  • EPS (₹)

    -25.10

  • Traded Value (₹ in Lakhs)

    23,133.88

  • 52 Week High

    1,679.90

  • 52 Week Low

    490.15

  • Price BSE

    1424.0

  • Price NSE

    1,424.00

  • Market Capital( in Cr.)

    23,133.88

  • P/C Ratio

    -99.70

  • P/E Ratio

    -56.70

  • Price Vs.BV

    -25.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 1,154.00 1,072.00 1,372.00 987.00 890.06 1,557.41
Excise Duty 1,091.00 983.00 1,122.00 879.00 704.36 1,423.13
Net Sales 1,154.00 1,072.00 1,372.00 987.00 890.06 1,557.41
Other Income 41.00 67.00 38.00 41.00 43.02 31.00
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 1,195.00 1,139.00 1,410.00 1,028.00 933.08 1,588.41
EXPENDITURE :
Raw Materials 1,091.00 983.00 1,122.00 879.00 704.36 1,423.13
Power & Fuel Cost 1,091.00 983.00 1,122.00 879.00 704.36 1,423.13
Employee Cost 247.00 240.00 261.00 293.00 325.46 345.69
Other Manufacturing Expenses 169.00 69.00 76.00 109.00 88.75 156.06
Selling & Administrative Expenses 177.00 178.00 181.00 166.00 180.29 267.81
Miscellaneous Expenses 169.00 69.00 76.00 109.00 88.75 156.06
Less : Pre-operative Expenses Capitalised :
Total Expenditure 1,603.00 1,417.00 1,594.00 1,509.00 1,416.76 1,910.07
Operating Profit 136.00 114.00 156.00 141.00 115.41 155.89
Interest 237.00 229.00 273.00 200.00 220.17 170.88
Gross Profit -422.00 -513.00 -184.00 -623.00 -483.68 -321.66
Depreciation 176.00 186.00 171.00 184.00 173.39 119.82
Profit Before Tax -422.00 -513.00 -184.00 -623.00 -483.68 -321.66
Tax 0.00 0.00 0.00 -136.00 -50.80 -51.10
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 -47.00 -49.00 -95.00 -110.89 -93.54
Reported Net Profit -422.00 -466.00 -140.00 -392.00 -325.68 -177.02
Extraordinary Items -422.00 -513.00 -184.00 -623.00 -483.68 -321.66
Adjusted Net Profit -422.00 -466.00 -140.00 -392.00 -325.68 -177.02
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 1,484.00 145.36 146.23
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -422.00 -466.00 -140.00 -392.00 -325.68 -177.02
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -29.27 -32.40 -11.62 49.36 -20.88 -7.40
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    49.09%

  • Public Share Holding

    50.91%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 78,578,797 48.36 78,578,797 8
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,180,051 0.73 1,180,051 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 79,758,848 49.09 79,758,848 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 29,540 0.02 29,540 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 630 0.00 130 4
Foreign Bank 10,200 0.01 10,200 2
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 10,623,262 6.54 10,622,062 110
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 767,712 0.47 766,312 4
Mutual Funds / UTI 11,581,662 7.13 11,581,662 15
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,597,695 2.21 3,597,695 16
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 26,610,701 16.38 26,607,601 152
2] Non Institution
Bodies Corporate 5,712,296 3.52 5,710,096 1,069
Clearing Members 3,551 0.00 3,551 13
Directors of their Relatives 295 0.00 295 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,214,407 1.36 2,209,607 3,617
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,995,235 1.23 1,995,235 3,402
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 12,754,306 7.85 12,754,306 78
Individuals holding nominal share capital up to Rs. 1 lakh 31,903,993 19.64 31,536,197 134,195
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 3,619 0.00 3,619 8
Others 320,904 0.20 320,904 2
Sub Total 56,102,770 34.53 55,727,974 142,544
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 162,472,319 100.00 162,094,423 142,710

Company Background

Wockhardt LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Wockhardt Ltd
  • BSE Code : 8021.0
  • ISIN : INE049B01025
  • Incorporation Year

    1999

  • Registered Office

    D-4 MIDC
    Chikalthana, Aurangabad.,
    Maharashtra-431006

  • Telephone

    91-240-6694444

  • FAX

    91-240-2489219

  • Chairman

    H F Khorakiwala

  • Managing Director

    Murtaza H Khorakiwala

  • Company Secretary

    Rashmi Mamtura

  • Auditor

    B S R & Co LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Wockhardt Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Wockhardt 1,423.75 1,195.00 1,154.00 -130.02 0.00
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92